Agenus
AGEN
$1.17
Share price
1.74%
Change (1 day)
-54.30%
Change (1 year)
Categories
Revenue for Agenus (AGEN)
Revenue in 2023 (TTM): $99.35 M
According to Agenus 's latest financial reports the company's current revenue (TTM) is $99.35 M. In 2022 the company made a revenue of $98.02 M a decrease over the years 2021 revenue that were of $0.29 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Agenus from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $99.35 M | 1.36% |
| 2022 | $98.02 M | -66.85% |
| 2021 | $0.29 B | 235.34% |
| 2020 | $88.16 M | -41.24% |
| 2019 | $0.15 B | 307.92% |
| 2018 | $36.78 M | -14.21% |
| 2017 | $42.87 M | 89.94% |
| 2016 | $22.57 M | -9.04% |
| 2015 | $24.81 M | 255.68% |
| 2014 | $6.97 M | 129.14% |
| 2013 | $3.04 M | -80.92% |
| 2012 | $15.96 M | 479.27% |
| 2011 | $2.75 M | -17.99% |
| 2010 | $3.35 M | 0.75% |
| 2009 | $3.33 M | 25.78% |
| 2008 | $2.65 M | -52.25% |
| 2007 | $5.55 M | 702.2% |
| 2006 | $0.69 M | 9.87% |
| 2005 | $0.62 M | -39.71% |
| 2004 | $1.04 M | -76.52% |
| 2003 | $4.44 M | 30.43% |
| 2002 | $3.41 M | -25.1% |
| 2001 | $4.55 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.76 B | 94,269.74% | 🇺🇸 USA |
 Merck MRK | $58.31 B | 58,588.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $45.18 B | 45,379.89% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $35.34 B | 35,478.82% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | $3.25 M | -96.72% | 🇺🇸 USA |